Evidence brief: The comparative effectiveness, harms, and cost-effectiveness of pharmacogenomics-guided antidepressant treatment versus usual care for major depressive disorder
Antidepressants are a mainstay of treatment for Major Depressive Disorder (MDD). To guide the choice of antidepressants, clinicians have typically taken a "trial and error" approach, informed by various clinical factors thought to be associated with variable treatment response. But rates o...
| Main Authors: | , , , |
|---|---|
| Corporate Authors: | , , |
| Format: | eBook |
| Language: | English |
| Published: |
Washington, DC
Department of Veterans Affairs, Health Services Research & Development Service
2016, May 2016
|
| Series: | Evidence-based synthesis program
|
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Table of Contents:
- Includes bibliographical references